Skip to main content

Advertisement

SpringerLink
Log in

Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Objective

In the present study, we aimed to evaluate the relationship between the survival rate of patients with esophageal squamous cell carcinoma (SCC) and expression of two biomarkers along with age, gender, tumor margin, depth of invasion, site of tumor, tumor diameter, tumor grade, number of involved nodes, and vascular invasion.

Materials and Methods

In this retrospective survey, medical records of patients referred to the Shohada-e Tajrish hospital during 2001 to 2005 were reviewed and subjects with definite diagnosis of SCC were included. Required data were extracted from the patients’ records, and their prepared paraffin-embedded tissue blocks were collected under supervision of two pathologists. Immunohistochemistry (IHC) analysis was performed at the Firoozgar hospital in Tehran, Iran.

Results

The studied population included 20 men (74%) and 7 women (26%). The mean age at diagnosis was 58 ± 22. Results showed significantly higher survival rates in women compared to men (85.7 vs. 40%) (p = 0.001) and in patients with well-differentiated tumors compared to poor-differentiated cases (20 vs. 5%) (p = 0.004). No significant relationship was found between p53 expression and prognostic factors like age, gender, the site, grade, and size of the tumor, depth of invasion, involvement of lymph nodes, and vascular invasion.

Conclusion

Positivity of p53 and cyclin D1 was not found to be predictive of survival in patients with esophageal SCC which might be due to the small sample size of the present survey. Further investigations with larger sample populations and longer follow-ups are required to evaluate this correlation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

    Article  PubMed  Google Scholar 

  2. Allameh A, Rasmi Y, Nasseri-Moghaddam S, Tavangar SM, Sharifi R, Sadreddini M. Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects. Cancer Epidemiol. 2009;33(1):79–84.

    Article  CAS  PubMed  Google Scholar 

  3. Li H, Xiao W, Ma J, Zhang Y, Li R, Ye J, et al. Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2014;7(11):7989–98.

    PubMed  PubMed Central  Google Scholar 

  4. Munoz N. Epidemiological aspects of oesophageal cancer. Endoscopy. 1993;25(09):609–12.

    Article  CAS  PubMed  Google Scholar 

  5. Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54(4):594–606.

    Article  CAS  PubMed  Google Scholar 

  6. Pisani P, Parkin D, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer. 1993;55(6):891–903.

    Article  CAS  PubMed  Google Scholar 

  7. Lam AKY. Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol. 2000;33(2):71–90.

    Article  CAS  PubMed  Google Scholar 

  8. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.

    Article  PubMed  Google Scholar 

  9. Shadi Kolahdoozan MDM, Alireza Sadjadi MDM, Radmard AR, Hooman Khademi MDM. Five common cancers in Iran. Archives of Iranian medicine. 2010;13(2):143.

    PubMed  Google Scholar 

  10. Chava S, Mohan V, Shetty P, Manolla M, Vaidya S, Khan I, et al. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer. Dis Esophagus. 2012;25(1):81–7.

    Article  CAS  PubMed  Google Scholar 

  11. Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A, Ogoshi S. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer. 1998;77(1):92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kawakubo H, Ozawa S, Ando N, Kitagawa Y, Mukai M, Ueda M, et al. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. Oncol Rep. 2005;14(6):1453–60.

    CAS  PubMed  Google Scholar 

  13. Vaninetti NM, Geldenhuys L, Porter GA, Risch H, Hainaut P, Guernsey DL, et al. Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma. Mol Carcinog. 2008;47(4):275–85.

    Article  CAS  PubMed  Google Scholar 

  14. Wang G, Abnet C, Shen Q, Lewin K, Sun X, Roth M, et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut. 2005;54(2):187–92.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Baldin V, Lukas J, Marcote M, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7(5):812–21.

    Article  CAS  PubMed  Google Scholar 

  16. Makino T, Yamasaki M, Miyata H, Yoshioka S, Takiguchi S, Fujiwara Y, et al. p53 mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. Ann Surg Oncol. 2010;17(3):804–11.

    Article  PubMed  Google Scholar 

  17. Naganuma S, Whelan KA, Natsuizaka M, Kagawa S, Kinugasa H, Chang S, et al. Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma. Am J Cancer Res. 2012;2(4):459–475.

  18. Nozoe T, Maehara Y. Over-expression of p53 protein in esophageal squamous cell carcinoma of women. Hepato-Gastroenterology. 2005;53(67):73–6.

    Google Scholar 

  19. Nakajima Y, Nagai K, Miyake S, Ohashi K, Kawano T, Iwai T. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn J Cancer Res. 2002;93(3):305–12.

    Article  CAS  PubMed  Google Scholar 

  20. Zhao J, Li L, Wei S, Gao Y, Chen Y, Wang G, et al. Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis. Dis Esophagus. 2012;25(6):520–6.

    Article  CAS  PubMed  Google Scholar 

  21. Mirinezhad SK, Somi MH, Jangjoo AG, Seyednezhad F, Dastgiri S, Mohammadzadeh M, et al. Survival rate and prognostic factors of esophageal cancer in East Azerbaijan province, north-west of Iran. Asian Pac J Cancer Prev. 2012;13(7):3451–4.

    Article  PubMed  Google Scholar 

  22. Hajian-Tilaki K. Factors affecting the survival of patients with oesophageal carcinoma under radiotherapy in the north of Iran. Br J Cancer. 2001;85(11):1671.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Van Andel J, Dees J, Dijkhuis C, Fokkens W, Van Houten H, De Jong P, et al. Carcinoma of the esophagus: results of treatment. Ann Surg. 1979;190(6):684.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kinoshita Y, Endo M, Nakayama K, Sato H. Evaluation of ten-year survival after operation for upper-and mid-thoracic esophageal cancer. Int Adv Surg Oncol. 1977;1:173–200.

    Google Scholar 

  25. Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, Makino T, et al. Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer. 1999;80(8)

  26. Jeremic B, Shibamoto Y, Acimovic L, Matovic Z, Milicic B, Milisavljevic S, et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys. 1998;40(5):1061–6.

    Article  CAS  PubMed  Google Scholar 

  27. Malhaire J-P, Lozac'h P, Simon H, Labat J-P, Topart P, Lucas B, et al. Split-course concomitant radiochemotherapy plus surgery vs. surgery alone in squamous cell carcinoma of the esophagus. A non-randomized retrospective study of 184 patients. Bull Cancer. 1997;84(4):357–67.

    CAS  PubMed  Google Scholar 

  28. Kolh P, Honore P, Gielen J, Degauque C, Azzam C, Legrand M, et al. Analysis of factors influencing long-term survival after surgical resection for oesophageal squamous cell carcinoma. Acta Chir Belg. 1998;99(3):113–8.

    Google Scholar 

  29. Launois B, Paul J, Lygidakis N, Campion J, Malledant Y, Grossetti D, et al. Results of the surgical treatment of carcinoma of the esophagus. Surgery, gynecology & obstetrics. 1983;156(6):753–60.

    CAS  Google Scholar 

  30. Petrequin P, Huguier M, Lacaine F, Houry S. Surgically treated esophageal cancers: predictive model of survival. Gastroenterologie clinique et biologique. 1996;21(1):12–6.

    Google Scholar 

  31. Slevin NJ, Stout R. Carcinoma of the oesophagus—a review of 108 cases treated by radical radiotherapy. Clin Radiol. 1989;40(2):200–3.

    Article  CAS  PubMed  Google Scholar 

  32. Giuli R, Gignoux M. Treatment of carcinoma of the esophagus: retrospective study of 2,400 patients. Ann Surg. 1980;192(1):44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Roshandel G, Merat S, Sotoudeh M, Khoshnia M, Poustchi H, Lao-Sirieix P, et al. Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in northern Iran. Br J Cancer. 2014;111(12):2235–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the Cancer Research Center of Shahid Beheshti University of Medical Sciences for their kind cooperation and financial support.

Author information

Authors and Affiliations

  1. Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Nazanin Saemi, Jalaleddin Khoshnevis, Mohammad Esmaeil Akbari, Barmak Gholizadeh, Leila Larijani & Afshin Moradi

  2. Medical Biotechnology Department, Iran University of Medical Sciences, Tehran, Iran

    Nazanin Saemi, Maryam Baikpour & Hanieh Zham

  3. Community Medicine Department, Medical Faculty, Tehran University of Medical Sciences, Tehran, Iran

    Alipasha Meysamie

  4. Cellular and Molecular Research Center, Faculty of Allied Sciences, Iran University of Medical Sciences, Tehran, Iran

    Alireza Korourian

  5. Department of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Masoud Baikpour

  6. Cancer Research Center (CRC), Tajrish Shohada Hospital, Dr. Sharieati street, Ghods square, Tehran, Iran

    Hanieh Zham

Authors
  1. Nazanin Saemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jalaleddin Khoshnevis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Esmaeil Akbari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alipasha Meysamie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alireza Korourian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Barmak Gholizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Leila Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Afshin Moradi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masoud Baikpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Maryam Baikpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hanieh Zham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hanieh Zham.

Ethics declarations

Funding

This study was funded by the Cancer Research Center of Shahid Beheshti University of Medical Sciences.

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saemi, N., Khoshnevis, J., Akbari, M.E. et al. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors. J Gastrointest Canc 49, 35–40 (2018). https://doi.org/10.1007/s12029-016-9905-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-016-9905-6

Keywords

Search

Navigation